box10.gif (1299 bytes)








John Soloninka becomes  president & CEO at HTX

TORONTO – John Soloninka (pictured) has been selected as HTX’s new President and CEO, effective July 19, 2010. The appointment was announced by Peter Goodhand, Board Chair of HTX. “We are tremendously pleased that John will be leading the HTX team on its new, expanded mission,” said Goodhand.

HTX is an Ontario-Government-funded non-profit organization that helps small, medium-sized and multi-national companies accelerate the development, evaluation, commercialization, sale and export of medical technology (devices, diagnostics, imaging, eHealth, wireless, home health, and chronic disease management).

The Ontario Ministry of Research and Innovation announced in April that HTX will receive $21.4 million to fund the Healthcare Technology Commercialization Program (HTCP), part of Ontario’s aggressive Life Sciences Commercialization Strategy.

Goodhand observed: “John brings a valuable breadth of experience to HTX, from serial entrepreneur, to consultant for both industry and government, to executive roles in both public SME companies and globally integrated organizations. He knows HTX, its mission and stakeholders, through conducting the original SWOT analysis in 2002 which formed the basis for HTX, and his volunteer involvement with HTX and its many initiatives and proposal development over the last six years. Throughout his various roles John has been a passionate champion and advocate for investment and collaborative innovation in the development of the sector.”

Soloninka was selected through an extensive executive search attracting a number of exceptional candidates. “I am thrilled to be coming on board at such an exciting time for the organization” said Soloninka. “The HTCP will be an outstanding resource for young and large companies alike. Mickey (Dr. Morris Milner, outgoing HTX President and CEO) and the HTX team have an outstanding track record. It is a privilege to join a high-functioning team, and to build the organization to the next level on that foundation.”

Soloninka has over 23 years of experience in medical technology consulting, company formation, growth and management. He has led major projects in health system transformation, biopharma/device development/regulation, health IT, disease management, clinical trials, clinical genomics, and venture capital for Price Waterhouse, Soloninka and Associates and IBM.

A Professional Engineer and MBA, Mr. Soloninka was a founder, senior executive and leader in start-up companies in oncology, radiology and internet-based EMR and clinical trials which were variously sold to Varian Medical Systems, Merge Technologies and Assisted, all of the U.S. He comes to HTX from his most recent role as healthcare practice lead for IBM Global Business Services in Ontario.

Goodhand expressed sincere thanks to Dr. Milner, HTX’s outgoing President and CEO: “Mickey brought 30+ years in the research sector, including: 15 years as the VP of Research at Bloorview Kids Rehab; over 12 years as founder of the Ontario Rehabilitation Technology Consortium, for which over 33 assistive devices have been marketed; key contributions to the Medical and Assistive Technology Consortium; and, the last six years as the leader of HTX. His outstanding commitment to the community is truly an inspiration. Mickey is retiring from the role of President and CEO, but will continue to advise and support HTX. We wish him well in his future endeavors.”

About HTX
From Invention through to Innovation to International Invoice, HTX supports emerging and established Ontario-based companies to develop, produce and commercialize innovative market-leading advanced health technologies. HTX is funded by the Government of Ontario through the Ministry of Research and Innovation. For more information about our programs and services, please visit

Posted July 29, 2010